Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity. [electronic resource]
- Cancer immunology, immunotherapy : CII May 2006
- 547-57 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't